8-Cl-cAMP, a site-selective analogue of cAMP, decreased mdr-1 expression in multidrug-resistant human breast cancer cells. A sixfold reduction of mdr-1 mRNA expression by 8-Cl-cAMP began within 8 h of treatment and was associated with a decrease in the synthesis of P-glycoprotein and with an increase in vinblastine accumulation. A reduction in mdr-1 expression after 8-Cl-cAMP treatment was also observed in multidrug-resistant human ovarian cancer cell lines. 8-Cl-cAMP is known to change the ratio between the two regulatory subunits, RI and RII, of protein kinase A (PKA). We observed that RI alpha decreased within 24 h of 8-Cl-cAMP treatment, that RII beta increased after as few as 3 h of treatment, and that PKA catalytic activity remained unchanged during 48 h of 8-Cl-cAMP treatment. The results are consistent with the hypothesis that mdr-1 expression is regulated in part by changes in PKA isoenzyme levels. Although 8-Cl-cAMP has been used to differentiate cells in other model systems, the only differentiating effect that could be detected after 8-Cl-cAMP treatment in the MCF-7TH cells was an increase in cytokeratin expression. Evidence that the reduction of mdr-1 mRNA occurred at the level of gene transcription was obtained by measuring chloramphenicol acetyltransferase (CAT) mRNA in MCF-7TH cells transfected with an mdr-1 promoter-CAT construct prior to 8-Cl-cAMP treatment. Thus, 8-Cl-cAMP is able to downregulate mdr-1 expression and suggests a new approach to reversal of drug resistance in human breast cancer.
S Scala, A Budillon, Z Zhan, Y S Cho-Chung, J Jefferson, M Tsokos, S E Bates
Title and authors | Publication | Year |
---|---|---|
Biochemistry of Drug Resistance
S Ahmed, SC Ojha, M Najam-ul-Haq, M Younus, MZ Hashmi |
2021 | |
Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling
W Miklos, P Heffeter, C Pirker, S Hager, C Kowol, S Schoonhoven, M Stojanovic, B Keppler, W Berger |
Oncotarget | 2016 |
Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity
Z Wang, L Zhang, Z Ni, J Sun, H Gao, Z Cheng, J Xu, P Yin |
Tumor Biology | 2015 |
Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: A potential target for ‘two-in-one’ cancer chemoimmunotherapeutics
M Hussain, F Tang, J Liu, J Zhang, A Javeed |
Cancer Letters | 2015 |
Human chorionic gonadotropin decreases human breast cancer cell proliferation and promotes differentiation: hCG Promotes MCF-7 Cell Differentiation
XH Liao, Y Wang, N Wang, TB Yan, WJ Xing, L Zheng, DW Zhao, YQ Li, LY Liu, XG Sun, P Hu, TC Zhang |
IUBMB Life | 2014 |
Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-κB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells
TT Hien, HG Kim, EH Han, KW Kang, HG Jeong |
Molecular Nutrition & Food Research | 2010 |
Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil
M Pešić, A Podolski, L Rakić, S Ruždijić |
Investigational New Drugs | 2009 |
Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies
CP Wu, AM Calcagno, SV Ambudkar |
Current molecular pharmacology | 2008 |
The Role of Prostaglandin E Receptor-Dependent Signaling via cAMP in Mdr1b Gene Activation in Primary Rat Hepatocyte Cultures
C Ziemann, A Riecke, G Rüdell, E Oetjen, HJ Steinfelder, C Lass, GF Kahl, KI Hirsch-Ernst |
The Journal of pharmacology and experimental therapeutics | 2006 |
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
MF McCarty |
Integrative Cancer Therapies | 2004 |
Protein Kinase A as Target for Novel Integrated Strategies of Cancer Therapy
G Tortora, F Ciardiello |
Annals of the New York Academy of Sciences | 2002 |
Regulatory Subunits of PKA and Breast Cancer
WR Miller |
Annals of the New York Academy of Sciences | 2002 |
Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF
C Monville, C Fages, AM Feyens, V D'Hondt, C Guillet, A Vernallis, H Gascan, M Peschanski |
BMC cell biology | 2002 |
Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression
D Lamb, RA Steinberg |
Journal of Cellular Physiology | 2002 |
8-Cl-Adenosine Induces Growth Arrest without Differentiation of Primary Mouse Epidermal Keratinocytes
DT Dransfield, RD Griner, S Ray, M Keskintepe, WB Bollag |
Journal of Investigative Dermatology | 2001 |
8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNFα-induced apoptosis is via inactivation of NF-κB
Y Yin, PD Allen, L Jia, SM Kelsey, AC Newland |
Leukemia Research | 2001 |
Cyclic nucleotide analogs as biochemical tools and prospective drugs
F Schwede, E Maronde, HG Genieser, B Jastorff |
Pharmacology & Therapeutics | 2000 |
Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha
Y Yin, PD Allen, L Jia, MG Macey, SM Kelsey, AC Newland |
British Journal of Haematology | 2000 |
Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids
M Wartenberg, K Fischer, J Hescheler, H Sauer |
International Journal of Cancer | 2000 |
Inhibition of Cell Growth and Proliferation in Human Glioma Cells and Normal Human Astrocytes Induced by 8-Cl-cAMP and Tiazofurin
M Pesic, K Drabek, C Esler, S Ruzdijic, V Pejanovic, Z Pietrzkowski |
Nucleosides Nucleotides & Nucleic Acids | 2000 |
Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applications
G Tortora, F Ciardiello |
Annals of Oncology | 2000 |
Lack of modulation ofMDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant mcf-7 breast cancer cells
AM Parissenti, BR Gannon, DJ Villeneuve, AF Kirwan-rhude, A Chadderton, S Gl�ck |
International Journal of Cancer | 1999 |
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor
A Budillon, ED Gennaro, M Caraglia, D Barbarulo, A Abbruzzese, P Tagliaferri |
British Journal of Cancer | 1999 |
Cisplatin resistance in cyclic AMP-dependent protein kinase mutants
ME Cvijic, WL Yang, KV Chin |
Pharmacology & Therapeutics | 1998 |
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
RK Srivastava, AR Srivastava, SJ Korsmeyer, M Nesterova, YS Cho-Chung, DL Longo |
Molecular and cellular biology | 1998 |
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study
G Frasci, P Comella, G D'Aiuto, A Budillon, D Barbarulo, R Thomas, I Capasso, R Casaretti, A Daponte, F Caponigro, A Gravina, L Maiorino, G Caratení, A Gentile, G Comella |
Breast Cancer Research and Treatment | 1998 |
Transcriptional regulation of MDR genes
KW Scotto, DA Egan |
Cytotechnology | 1998 |
Protein kinases and multidrug resistance
MG Rumsby, L Drew, JR Warr |
Cytotechnology | 1998 |
Multiple Drug Resistance in Cancer 2
M Clynes |
1998 | |
Molecular events as targets of anticancer drug therapy
A AszalÓs, S Eckhardt |
Pathology & Oncology Research | 1997 |
Involvement of heat shock factor in regulating transcriptional activation of MDR1 gene in multidrug-resistant cells
SH Kim, WY Hur, CD Kang, YS Lim, DW Kim, BS Chung |
Cancer Letters | 1997 |
Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin
ME Cvijic, KV Chin |
International Journal of Cancer | 1997 |